High-density lipoprotein as a modulator of platelet and coagulation responses

High-Density Lipoprotein

(2014) Thomas F. Lüscher et al.   CIRCULATION RESEARCH

New players in haemostasis and thrombosis

(2014) Julia Geddings et al.   THROMBOSIS AND HAEMOSTASIS

Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids

(2013) Laurent Camont et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Carotid Atherosclerosis Predicts Future Myocardial Infarction But Not Venous Thromboembolism

(2013) Erin M. Hald et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality

(2013) G. Silbernagel et al.   EUROPEAN HEART JOURNAL

Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia

(2013) Catherine Calzada et al.   FASEB JOURNAL

Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis

(2013) Andrew J Murphy et al.   NATURE MEDICINE

Extrahepatic High-Density Lipoprotein Receptor SR-BI and ApoA-I Protect Against Deep Vein Thrombosis in Mice

(2012) Alexander Brill et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals

(2012) Michał Ząbczyk et al.   BLOOD COAGULATION & FIBRINOLYSIS

Association between venous and arterial thrombosis: Clinical implications

(2012) Massimo Franchini et al.   European Journal of Internal Medicine

The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes

(2012) John F. Martin et al.   Nature Reviews Cardiology

Lipid levels do not influence the risk of venous thromboembolism

(2012) I. M. van Schouwenburg et al.   THROMBOSIS AND HAEMOSTASIS

Fibrin Clot Structure and Function

(2011) Anetta Undas et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Competing Risk of Atherosclerotic Risk Factors for Arterial and Venous Thrombosis in a General Population: The Tromsø Study

(2011) Sigrid K. Brækkan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI

(2011) Martin F. Brodde et al.   ATHEROSCLEROSIS

Platelets at work in primary hemostasis

(2011) Katleen Broos et al.   BLOOD REVIEWS

HDL scavenger receptor class B type I and platelet function

(2011) Jerzy-Roch Nofer et al.   CURRENT OPINION IN LIPIDOLOGY

Cholesteryl Ester Transfer Protein Expression Partially Attenuates the Adverse Effects of SR-BI Receptor Deficiency on Cholesterol Metabolism and Atherosclerosis

(2011) Majda El Bouhassani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells

(2011) May Brundert et al.   JOURNAL OF LIPID RESEARCH

Genetic Variant of the Scavenger Receptor BI in Humans

(2011) Menno Vergeer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Role of Platelets in Atherothrombosis

(2011) Z. S. Kaplan et al.   Hematology-American Society of Hematology Education Program

Restoration of High-Density Lipoprotein Levels by Cholesteryl Ester Transfer Protein Expression in Scavenger Receptor Class B Type I (SR-BI) Knockout Mice Does Not Normalize Pathologies Associated With SR-BI Deficiency

(2010) Reeni B. Hildebrand et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Deletion of the High-Density Lipoprotein Receptor Scavenger Receptor BI in Mice Modulates Thrombosis Susceptibility and Indirectly Affects Platelet Function by Elevation of Plasma Free Cholesterol

(2010) Suzanne J.A. Korporaal et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Specific binding of hypochlorite-oxidized HDL to platelet CD36 triggers proinflammatory and procoagulant effects

(2010) Alice Assinger et al.   ATHEROSCLEROSIS

Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia

(2010) Y. Ma et al.   BLOOD

High-density lipoproteins, platelets and the pathogenesis of atherosclerosis

(2010) Jerzy-Roch Nofer et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

High-density lipoprotein heterogeneity and function in reverse cholesterol transport

(2010) George H Rothblat et al.   CURRENT OPINION IN LIPIDOLOGY

Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition

(2010) O. DANGEL et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes

(2010) C. OSLAKOVIC et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Contents

(2009)   AMERICAN JOURNAL OF CARDIOLOGY

HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk

(2009) M.T. Cooney et al.   ATHEROSCLEROSIS

HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study

(2009) Benoit J. Arsenault et al.   ATHEROSCLEROSIS

Risk of arterial cardiovascular events in patients after pulmonary embolism

(2009) F. A. Klok et al.   BLOOD

Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux

(2009) Anna C. Calkin et al.   CIRCULATION

The therapeutic potential of high-density lipoprotein mimetic agents in coronary artery disease

(2009) Philippe Meyer et al.   Current Atherosclerosis Reports

Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2)

(2009) P. Quist-Paulsen et al.   HAEMATOLOGICA

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Anionic Phospholipids Lose Their Procoagulant Properties When Incorporated into High Density Lipoproteins

(2009) Cecilia Oslakovic et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

HDL-cholesterol and future risk of venous thromboembolism: the Tromsø Study

(2009) S. K. BRAEKKAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women

(2009) B. M. EVERETT et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Thrombocytopenia and Platelet Abnormalities in High-Density Lipoprotein Receptor–Deficient Mice

(2008) Vandana S. Dole et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women

(2008) Stefania Lamon-Fava et al.   ATHEROSCLEROSIS

High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE)

(2008) A. M. Chamberlain et al.   BLOOD

Oxidation by hypochlorite converts protective HDL into a potent platelet agonist

(2008) Alice Assinger et al.   FEBS LETTERS

Cardiovascular Risk Factors and Venous Thromboembolism

(2007) Walter Ageno et al.   CIRCULATION